We have observed
10 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after July 10, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Detection of DNA that originates from a specific cell-type
Multiplex detection of DNA that originates from a specific cell-type
Antibody IgG1 with a modified heavy chain constant region
DETECTION OF DNA THAT ORIGINATES FROM A SPECIFIC CELL-TYPE AND RELATED METHODS
DETECTION OF FOETAL CHROMOSOMAL ANEUPLOIDIES USING DNA REGIONS THAT ARE DIFFERENTIALLY METHYLATED BETWEEN THE FOETUS AND THE PREGNANT FEMALE
IMPROVED METHOD OF MAPPING GLYCANS OF GLYCOPROTEINS IN SERUM SAMPLES
METHODS OF MAPPING PROTEIN VARIANTS
EPIGENETIC MARKERS AND RELATED METHODS AND MEANS FOR THE DETECTION AND MANAGEMENT OF OVARIAN CANCER